RQRui Qiao

Rui Qiao

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Rui Qiao has a total of 63 co-authors. Here are the top co-authors by number of shared publications:

  • Jie Zhang

    Department of Laboratory Medicine, Peking University International Hospital, Beijing 102206, China

    8 shared publications
  • Shuo Yang

    Laboratory Medicine, Peking University Third Hospital, Beijing, CHINA

    6 shared publications
  • Cheng Liu

    The Department of Laboratory Medicine Peking University Third Hospital Beijing China

    4 shared publications
  • Han Guo

    Department of Laboratory Medicine, Peking University Third Hospital, Beijing 100191, China

    4 shared publications
  • Yuncong Zhang

    Department of Laboratory Medicine, Peking University Third Hospital, Beijing 100191, China; Department of Clinical Laboratory, Beijing Jishuitan Hospital, Peking University Fourth School of Clinical Medicine, Beijing 100035, China

    4 shared publications
  • Aiwei Li

    Department of Education, Peking University Third Hospital, Beijing 100191, China

    3 shared publications

Latest Publications

  • Open Access

    Using Long Short-Term Memory and Causal Forest to Identify Preeclampsia Subtypes with Differential Aspirin Associations for Preterm Birth Prevention

    by Cheng Liu, Yang Su, Yao Wei, Yongxin Li, Chengxi Bao, Rui Qiao

    Aspirin prevents preterm birth in some women with preeclampsia but not others, yet no longitudinal multi-indicator study has examined subtype differences in aspirin response. We aimed to identify subtypes most likely to benefit. In this retrospective cohort of 53,362 deliveries (4505 preeclamptic women), we applied a two-stage machine learning framework using 15 indicators (14 laboratory tests plus systolic blood pressure) from two-time windows: before 16 weeks and within 2 weeks before delivery. A long short-term memory autoencoder with K-means clustering identified subtypes, and causal forest estimated the average treatment effect of aspirin on preterm birth (n = 345), characterised by mild liver enzyme elevation and coagulation abnormalities in late pregnancy, had the highest preterm birth rate (57.7%) and ICU admission rate (9.6%), and showed the largest aspirin-associated reduction in preterm birth (ATE −0.026, 95% CI: −0.032 to −0.021), consistent across 70/30 splits. Sensitivity analyses using 34 indicators confirmed similar effects (ATE −0.027, 95% CI: −0.031 to −0.023), while no benefit was observed in non-preeclamptic women. These findings suggest that aspirin prophylaxis may be associated with a greater reduction in preterm birth in this preeclampsia subtype, but further validation is required.

  • Open Access

    Reactive thrombocytosis in hospitalized pneumonia reflects intense inflammation and confers context-dependent mortality risk

    by Cheng Liu, Lili He, Yuanhao Guo, Yang Su, Yao Wei, Yongxin Li, Xiaolong Ma, Rui Qiao

    Beyond hemostasis, platelets’ immune and inflammatory role is recognized and thrombocytosis is generally regarded as a marker of the inflammatory res

  • Open Access

    Macrophage and Preeclampsia: Macrophage Polarization Imbalance at the Maternal‐Fetal Interface

    by Yao Wei, Yang Su, Cheng Liu, Xiaolong Ma, Zihui Ling, Yilin Wang, Rui Qiao

    Background: Preeclampsia (PE), as a pathological pregnancy process, is still unclear in its precise pathophysiology. The current consensus on PE pathogenesis is that it is an immune‐inflammatory response due to placental dysfunction leading to multiorgan involvement in the mother. Macrophages can polarize into different phenotypes under the influence of distinct microenvironments, secreting various cytokines or chemokines with distinct functions. These phenotypes play roles in either promoting inflammation or facilitating tissue repair. Studies have observed the increase in M1 polarization of decidual macrophages during the occurrence of PE, with this polarization imbalance contributing to the immuno‐inflammatory response involved in placental formation. Therefore, understanding the polarization characteristics of macrophages provides a valuable direction for research related to the prevention and treatment of PE.Methods: Authors searched for related literature on PubMed using the professional terms “preeclampsia” and “macrophage polarization”. The obtained literature was categorized according to its research. Similar articles are summarized in the same sections, which are divided into different small sections according to their specific contents.Results: Different studies have explored the metabolic characteristics, surface markers, secretions, signaling pathways, and functions of different macrophage polarization types, highlighting the critical role of polarization imbalance and excessive inflammatory responses in the development of PE. Intervening in inflammatory responses at the maternal‐fetal interface holds significant value for the prevention and treatment of PE.Conclusion: Understanding the metabolic characteristics of different macrophage polarization types, combined with their polarization imbalance during the development of PE, can facilitate targeted prevention of PE.


  • Open Access

    The platelet storage lesion, what are we working for?

    by Cheng Liu, Yang Su, Wanwan Guo, Xiaolong Ma, Rui Qiao

    Background: Platelet concentrate (PC) transfusions are crucial in prevention and treatment of bleeding in infection, surgery, leukemia, and thrombocytopenia patients. Although the technology for platelet preparation and storage has evolved over the decades, there are still challenges in the demand for platelets in blood banks because the platelet shelf life is limited to 5 days due to bacterial contamination and platelet storage lesions (PSLs) at 20–24°C under constant horizontal agitation. In addition, the relations between some adverse effects of platelet transfusions and PSLs have also been considered. Therefore, understanding the mechanisms of PSLs is conducive to obtaining high quality platelets and facilitating safe and effective platelet transfusions.Objective: This review summarizes developments in mechanistic research of PSLs and their relationship with clinical practice, providing insights for future research.Methods: Authors conducted a search on PubMed and Web of Science using the professional terms “PSL” and “platelet transfusion.” The obtained literature was then roughly categorized based on their research content. Similar studies were grouped into the same sections, and further searches were conducted based on the keywords of each section.Results: Different studies have explored PSLs from various perspectives, including changes in platelet morphology, surface molecules, biological response modifiers (BMRs), metabolism, and proteins and RNA, in an attempt to monitor PSLs and identify intervention targets that could alleviate PSLs. Moreover, novel platelet storage conditions, including platelet additive solutions (PAS) and reconsidered cold storage methods, are explored. There are two approaches to obtaining high‐quality platelets. One approach simulates the in vivo environment to maintain platelet activity, while the other keeps platelets at a low activity level in vitro under low temperatures.Conclusion: Understanding PSLs helps us identify good intervention targets and assess the therapeutic effects of different PSLs stages for different patients.


  • Open Access

    Anti-phosphatidylserine/prothrombin complex antibodies (aPS/PT) increase the risk for thrombosis based on lupus anticoagulant positivity

    by Yuncong Zhang, Yang Su, Han Guo, Lu Wang, Aiwei Li, Chanjuan Wang, Jie Zhang, Rui Qiao


  • Recombinant protein diannexin prevents preeclampsia-like symptoms in a pregnant mouse model via reducing the release of microparticles

    by Han Guo, Yuncong Zhang, Yaxin Chu, Shuo Yang, Jie Zhang, Rui Qiao

    Preeclampsia (PE) is characterized by placenta-mediated pregnancy complication. The only effective treatment for PE is the delivery of the placenta. However, this treatment may cause preterm birth and neonatal death. Therefore, preventing PE is needed. The mechanism of PE involves abnormal placentation, which leads to the release of anti-angiogenic and inflammatory mediators into maternal circulation. These mediators contribute to systemic vascular dysfunction, inflammatory responses, and excessive thrombin generation. Microparticles (MPs) are reportedly involved in PE by promoting the thromboinflammatory response. This study describes a strategy to prevent PE by reducing MP release using the recombinant protein, diannexin. Results showed that the patients with PE had elevated MP number and procoagulant activity and increased NLRP3 inflammasome activation. Additionally, diannexin remarkably reduced the release of MPs from activated cells by binding to phosphatidylserine exposed on the surface of activated cells. Moreover, in vivo results showed that diannexin could prevent PE-like symptoms by decreasing MPs and NLRP3 inflammasome activation in pregnant mice. Furthermore, diannexin effectively inhibited trophoblast cell activation and NLRP3 inflammasome activation in vitro. These findings suggested that diannexin inhibited MP release and might be an effective therapeutic strategy for preventing PE.


  • Open Access

    Effect of image-guided systems in phacoemulsification with intraocular lens (IOL) implantation: a systematic review and meta-analysis

    by Yang Su, Min Fu, Yifan Chen, Rui Qiao, Guo-Guo Yi

    To explore the effect of image-guided systems in phacoemulsification with intraocular lens (IOL) implantation.We searched Pubmed, Embase and China National Knowledge Infrastructure (inception to Ja...


  • Open Access

    Procoagulant platelets: Generation, characteristics, and therapeutic target

    by Yaxin Chu, Han Guo, Yuncong Zhang, Rui Qiao

    Platelets play a pivotal role in hemostasis. Activated platelets are classified into two groups, according to their agonist response: aggregating and procoagulant platelets. Aggregating platelets consist of activated integrin αIIbβ3 and stretch out pseudopods to further attract platelets to the site of injury by connecting with fibrinogen. They mainly gather in the core of the thrombus and perform a secretory function, such as releasing adenosine diphosphate (ADP). Procoagulant platelets promote the formation of thrombin and fibrin by interacting with coagulation factors and can thus be considered as the connector between primary and secondary hemostasis. In addition to their functions in blood coagulation, procoagulant platelets play a proinflammatory role by releasing platelet microparticles and inorganic polyphosphate. Considering these important functions of procoagulant platelets, this subpopulation warrants detailed study to analyze their potential in preventing human diseases. This review summarizes the generation and important characteristics of procoagulant platelets, as well as their potential for preventing the adverse effects associated with current antiplatelet therapies.


  • Open Access

    Prenatal Plasma Fibrinogen Level Predicts Postpartum Hemorrhage of Patients With HELLP Syndrome

    by Chanjuan Cui, Sisi Ma, Rui Qiao

    Hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome is a serious complication of pregnancy. Postpartum hemorrhage indicates poor prognosis of pregnant women with HELLP syndrome. The aim of our study is to investigate the predictive value of coagulation markers for postpartum hemorrhage of pregnant women with HELLP syndrome. In a retrospective cohort study, 106 patients who were diagnosed as pregnant women with HELLP syndrome in Peking University Third Hospital from August 2010 to January 2017 were analyzed. The demographic characters of maternal and fetus, days of hospital stay, postpartum complications, and the laboratory tests of coagulation markers within 3 days before delivery were collected. In addition, 100 healthy pregnant women were collected as a control group. The result showed that the incidence of preeclampsia in pregnant women with postpartum hemorrhage was higher than that in pregnant women without hemorrhage (P = .011). The level of fibrinogen (FIB) in postpartum hemorrhage pregnant women with HELLP syndrome was lower than that in nonpostpartum hemorrhage pregnant women with HELLP syndrome and healthy pregnant women (2.3 [1.68-2.81] vs 3.64 ± 0.95, P = .000; 2.3 [1.68-2.81] vs 4.48 ± 0.62, P = .000). Multivariate analysis showed that decreased FIB levels independently predicted the postpartum hemorrhage of pregnant women with HELLP syndrome (odds ratio = 7.374, 95% confidence interval [CI], 1.551-35.05, P = .012). The receiver operating characteristic curve showed that the area under the curve of FIB level when predicting postpartum hemorrhage is 0.841 (95% CI, 0.708-0.976). When the cutoff value of FIB was 3.04 g/L, the sensitivity was 90.90% and the specificity was75.80%. Therefore, the low level of prenatal FIB is a reliable biomarker to predict postpartum hemorrhage of pregnant women with HELLP syndrome, which make it useful for pregnant women with HELLP syndrome in guiding surveillance therapy and prognosis assessment.


  • Anti-domain 1 of beta2-glycoprotein I aids risk stratification in lupus anticoagulant-positive patients

    by Han Guo, Yuncong Zhang, Aiwei Li, Chanjuan Wang, Shuo Yang, Yinmei Zhang, Jie Zhang, Rui Qiao